ArticleG3 (Bethesda, Md.)2022

Correction to: Identification of pathways modulating vemurafenib resistance in melanoma cells via a genome-wide CRISPR/Cas9 screen.

Corinna Jie Hui Goh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.